Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Addiction Science & Clinical Practice
Published in: Addiction Science & Clinical Practice 1/2016

Open Access 01-12-2016 | Study Protocol

Examining multi-session brief intervention for substance use in primary care: research methods of a randomized controlled trial

Authors: Jaclyn E. Chambers, Adam C. Brooks, Rachel Medvin, David S. Metzger, Jennifer Lauby, Carolyn M. Carpenedo, Kevin E. Favor, Kimberly C. Kirby

Published in: Addiction Science & Clinical Practice | Issue 1/2016

Login to get access

Abstract

Background

Brief interventions such as Screening, a single session of Brief Intervention, and Referral to Treatment (SBIRT) have shown mixed effectiveness in primary care. However, there are indications that multi-session brief interventions may demonstrate more consistently positive outcomes, and perhaps a more intensive approach would be of benefit in addressing substance use in primary care. This study compared the effectiveness of SBIRT with a single BI session (BI/RT) to a multi-session brief-treatment intervention (BI/RT+) in primary care. We also developed easy-to-use, evidence-based materials to assist clinicians in delivering these interventions.

Methods/design

This study was conducted in three Federally Qualified Healthcare Centers (FQHCs). A total of 10,935 patients were screened, and 600 individuals were recruited. The sample was primarily Black/African American (82 %) with a mean age of 40. Patients who attended a healthcare appointment were screened for substance use via the AUDIT and DAST. Patients were eligible for the study if they scored 8 or higher on the AUDIT, were using only marijuana and scored 2 or higher on the DAST, or were using other illicit drugs and scored 1 or higher on the DAST. Participants were randomly assigned to receive one-session BI/RT, or two to six sessions of brief intervention that incorporated elements of motivational enhancement therapy and cognitive-behavioral therapy (BI/RT+). Both interventions were delivered by behavioral health consultants at the FQHCs. Participants completed follow-up assessments every 3 months for 1 year. Primary outcome variables included substance use treatment sessions attended and days of substance use. Secondary outcomes included measures of health, employment, legal, and psychiatric functioning and HIV risk behaviors. Additionally, we will conduct an economic evaluation examining cost-effectiveness and will analyze outcomes from a process evaluation examining patient and provider experiences.

Discussion

The ability of brief interventions to impact substance use has great potential, but research findings have been mixed. By conducting a large-scale randomized controlled trial in real-world health centers, this study will answer important questions about the effectiveness of expanded BIs for patients who screen positive for risky substance use in primary care.
Trial registration NCT01751672
Literature
1.
SAMHSA. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-46, Publication No. (SMA) 13-4795. Rockville, MD;2013.
2.
Chalk M, Dilonardo J, Rinaldo SG, Oehlmann P. Integrating appropriate services for substance use conditions in health care settings: an issue brief on lessons learned and challenges ahead. Philadelphia: Treatment Research Institute; 2010.
3.
Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend. 2008;97(3):226–30.CrossRefPubMedPubMedCentral
4.
Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003;163(20):2511–7.CrossRefPubMed
5.
Mertens JR, Weisner C, Ray GT, Fireman B, Walsh K. Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res. 2005;29(6):989–98.CrossRefPubMed
6.
Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abuse. 2007;28(3):7–30.CrossRef
7.
Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88(3):315–35.CrossRefPubMed
8.
Moyer A, Finney JW, Swearingen CE, Vergun P. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction. 2002;97(3):279–92.CrossRefPubMed
9.
Wilk AI, Jensen NM, Havighurst TC. Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med. 1997;12(5):274–83.CrossRefPubMedPubMedCentral
10.
Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Int Med. 2004;140(7):557–68.CrossRefPubMed
11.
Ballesteros J, Duffy JC, Querejeta I, Arino J, Gonzalez-Pinto A. Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses. Alcohol Clin Exp Res. 2004;28(4):608–18.CrossRefPubMed
12.
Kahan M, Wilson L, Becker L. Effectiveness of physician-based interventions with problem drinkers: a review. Can Med Assoc J. 1995;152(6):851–9.
13.
Jonas DE, Garbutt JC, Amick HR, et al. Behavioral counseling after screening for alcohol misuse in primary care: a systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2012;157(9):645–54.CrossRefPubMed
14.
Glass JE, Hamilton AM, Powell BJ, Perron BE, Brown RT, Ilgen MA. Speciality substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials. Addiction. 2015;110(9):1404–15.CrossRefPubMed
15.
Kaner E, Bland M, Cassidy P, et al. Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial. Br Med J. 2013;346:e8501.CrossRef
16.
van Beurden I, Anderson P, Akkermans RP, Grol RP, Wensing M, Laurant MG. Involvement of general practitioners in managing alcohol problems: a randomized controlled trial of a tailored improvement programme. Addiction. 2012;107(9):1601–11.CrossRefPubMed
17.
Aalto M, Saksanen R, Laine P, et al. Brief intervention for female heavy drinkers in routine general practice: a 3-year randomized, controlled study. Alcohol Clin Exp Res. 2000;24(11):1680–6.CrossRefPubMed
18.
Beich A, Gannik D, Malterud K. Screening and brief intervention for excessive alcohol use: qualitative interview study of the experiences of general practitioners. BMJ. 2002;325:870.CrossRefPubMedPubMedCentral
19.
Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alcohol Depend. 2005;77(1):49–59.CrossRefPubMed
20.
Zahradnik A, Otto C, Crackau B, et al. Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients. Addiction. 2009;104(1):109–17.CrossRefPubMed
21.
World Health Organization. The effectiveness of a brief intervention for illicit drugs linked to the alcohol, smoking, and substance involvement screening test (ASSIST) in primary health care settings: A technical report of phase III findings of the WHO ASSIST randomized controlled trial. Switzerland: World Health Organization; 2008.
22.
Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark HW. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alcohol Depend. 2009;99(1–3):280–95.CrossRefPubMedPubMedCentral
23.
Saitz R, Palfai TP, Cheng DM, et al. Screening and brief intervention for drug use in primary care: the ASPIRE randomized clinical trial. JAMA. 2014;312(5):502–13.CrossRefPubMedPubMedCentral
24.
Roy-Byrne P, Bumgardner K, Krupski A, et al. Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA. 2014;312(5):492–501.CrossRefPubMedPubMedCentral
25.
26.
Miller WR, Zweben A, DiClemente CC, Rychtarik RG. Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. In: Mattson ME, editor. National Institute on Alcohol Abuse and Alcoholism Project MATCH Monograph Series, vol. 2. Rockville: U.S. Department of Health and Human Services; 1995.
27.
Project MATCH. Matching alcoholism treatments to client heterogeneity: project MATCH post-treatment drinking outcomes. J Stud Alcohol. 1997;58(1):7–29.CrossRef
28.
Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96(12):1725–42.CrossRefPubMed
29.
Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71(5):843–61.CrossRefPubMed
30.
Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1(1):91–111.CrossRefPubMed
31.
Baker A, Lee NK, Claire M, et al. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction. 2005;100(3):367–78.CrossRefPubMed
32.
Copeland J, Swift W, Roffman R, Stephens R. A randomized controlled trial of brief cognitive–behavioral interventions for cannabis use disorder. J Subst Abuse Treat. 2001;21(2):55–64.CrossRefPubMed
33.
Covi L, Hess JM, Schroeder JR, Preston KL. A dose response study of cognitive behavioral therapy in cocaine abusers. J Subst Abuse Treat. 2002;23(3):191–7.CrossRefPubMed
34.
Anton RF, O’Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17.CrossRefPubMed
35.
Marijuana Treatment Project Resarch Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72(3):455–66.CrossRef
36.
Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. J Am Med Assoc. 2001;286(14):1715–23.CrossRef
37.
Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. [Erratum appears in J Perinatol. 2009 Feb;29(2):181]. J Perinatol. 2008;28(9):597–603.CrossRefPubMed
38.
Mertens JR, Flisher AJ, Satre DD, Weisner CM. The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Drug Alcohol Depend. 2008;98(1–2):45–53.CrossRefPubMedPubMedCentral
39.
Curry SJ, Ludman EJ, Grothaus LC, Donovan D, Kim E. A randomized trial of a brief primary-care based intervention for reducing at-risk drinking practices. Health Psychol. 2003;22(2):156–65.CrossRefPubMed
40.
Holland CL, Pringle JL, Barbetti V. Identification of physician barriers to the application of screening and brief intervention for problem alcohol and drug use. Alcohol Treat Q. 2009;27(2):174–83.CrossRef
41.
Goplerud E, McPherson T. Implementation barriers to and faciltators of screening, brief intervention, referral, and treatment (SBIRT) in Federally Qualified Health Centers (FQHCs): U.S. Department of Health and Human Services; 2015.
42.
Hennessey J. FQHCs and health reform: up to the task? Northwest J Law Soc Policy. 2013;9(1):122–37.
43.
Ku LRP, Dor A, Tan E, Shin P, Rosenbaum S. Strengthening primary care to bend the cost curve: the expansion of community health centers through health reform. Washington, DC: Geiger Gibson/RCHN Community Health Foundation Research Collaborative, George Washington University; 2010.
44.
Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addiction. 1993;88(6):791–804.CrossRefPubMed
45.
46.
Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the alcohol use disorders identification test (AUDIT). Alcohol Clin Exp Res. 1997;21(4):613–9.CrossRefPubMed
47.
Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess. 2000;12(2):186–92.CrossRefPubMed
48.
Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the drug abuse screening test. J Subst Abuse Treat. 2007;32(2):189–98.CrossRefPubMed
49.
Miller WR, Rollnick S. Motivational interviewing: preparing people for change. 2nd ed. New York: Guilford Press; 2002.
50.
McLellan AT, Cacciola JC, Alterman AI, Rikoon SH, Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict. 2006;15(2):113–24.CrossRefPubMed
51.
McLellan AT, Luborsky L, Erdlen F, Laporte D. The Addiction Severity Index: a diagnostic/evaluative instrument for substance abuse clients. In: Gottheil E, et al., editors. Substance abuse and psychiatric illness. New York: Pergamom Press; 1980.
52.
Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.PubMed
53.
Laudet AB, Morgen K, White WL. The role of social supports, spirituality, religiousness, life meaning and affiliation with 12-Step fellowships in quality of life satisfaction among individuals in recovery from alcohol and drug problems. Alcohol Treat Q. 2006;24(1–2):33–73.CrossRefPubMedPubMedCentral
54.
Cohen S, Williamson G. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, editors. The social psychology of health. Newbury Park: Sage; 1988.
55.
Carroll KM, Nich C, Sifry RL, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000;57(3):225–38.CrossRefPubMed
56.
Hauck WW, Anderson S, Marcus SM. Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials. 1998;19(3):249–56.CrossRefPubMed
57.
Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary: SAS Institute Inc.; 1996.
58.
Diggle PJ, Heagerty PJ, Laing KY, Zeger SL. Analysis of longitudinal data. 2nd ed. Oxford: Oxford University Press; 2002.
59.
Hedeker D, Gibbons RD, Waternaux C. Sample size estimation for longitudinal designs with attrition: comparing time-related contrasts between two groups. J Educ Behav Stat. 1999;24(1):70–92.CrossRef
60.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.
61.
Miller WR, Zweben A, DiClemente CC, Rychartik RG. Motivational enhancement therapy manual: a clinical research guide for therapists treating individuals with alcohol abuse and dependence. Rockville: National Institute on Alcohol Abuse and Alcoholism; 1992.
62.
McLellan AT, O’Brien CP, Lewis DL, Kleber HD. Drug addiction as a chronic medical illness: implications for treatment, incusrance and evaluation. J Am Med Assoc. 2000;284:1689–95.CrossRef
63.
McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–58.CrossRefPubMed
Metadata
Title
Examining multi-session brief intervention for substance use in primary care: research methods of a randomized controlled trial
Authors
Jaclyn E. Chambers
Adam C. Brooks
Rachel Medvin
David S. Metzger
Jennifer Lauby
Carolyn M. Carpenedo
Kevin E. Favor
Kimberly C. Kirby
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2016
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-016-0057-6

Other articles of this Issue 1/2016

Addiction Science & Clinical Practice 1/2016 Go to the issue

Reviewer acknowledgement

Acknowledgement of manuscript reviewers 2015

Case study

Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic

Study Protocol

Finding harmony so the music plays on: pragmatic trial design considerations to promote organizational sustainment of an empirically-supported behavior therapy

Study Protocol

A computer-assisted motivational social network intervention to reduce alcohol, drug and HIV risk behaviors among Housing First residents

Study Protocol

Study protocol for a web-based personalized normative feedback alcohol intervention for young adult veterans

Research

Emerging adults in substance misuse intervention: preintervention characteristics and responses to a motivation-enhancing program